Abstract
Objective
To assess the usefulness of dialysis with the molecular adsorbent recirculating system (MARS) in patients with acute liver failure who fulfil criteria for liver transplantation.
Design
Observational cohort study.
Setting
ICU at a liver transplantation centre.
Patients
Twenty-two patients (23 episodes) received MARS dialysis. They were either listed for LT (n = 14), delayed (n = 1), or not listed (contra-indication, n = 7).
Interventions
A total of 56 MARS treatments (median per patient 2; mean duration 7.6 ± 2.6 h) were performed on haemodialysis.
Measurements and results
Clinical and biological variables were assessed before and 24 h after MARS therapy. The rate of recovery of liver function without transplantation was compared with an expected rate and survival was analysed.
Following MARS dialysis, we observed an improvement in the grade of hepatic encephalopathy (P = 0.02) and the Glasgow coma score (P = 0.02), a decrease in conjugated bilirubin (P = 0.05) and INR (P = 0.006), and an increase in prothrombin index (P = 0.005). Overall, liver function improved in seven patients (32%): four listed patients in whom transplantation could be avoided and three patients among those not listed due to contra-indications. The transplant-free recovery rate in listed patients was 29% (vs. expected 9%, P = 0.036). Listed patients (n = 14) had a higher 30-day survival rate [86% (12/14) vs 38% (3/8), P = 0.05] and a higher long-term survival rate (P = 0.02).
Conclusions
A statistically significant improvement of liver function was observed after MARS therapy. Transplant-free recovery was more frequent than expected. The apparent benefit of MARS dialysis to treat acute liver failure needs to be confirmed by a controlled study.
Similar content being viewed by others
References
Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Lohr JM, Liebe S, Emmrich J, Korten G, Schmidt R (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6:277–286
Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, Schmidt R, Stange J (2002) Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 36:949–958
Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou JP (2000) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6:648–651
O'Grady JG, Alexander GJM, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439–445
Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP (1996) Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 16:415–425
Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J (2000) Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 6:163–169
Camus C, Person A, Signouret T, Lavoué S, Gacouin A, Le Tulzo Y, Lorho R, Boudjéma K, Thomas R (2004) Albumin dialysis (MARS system) in patients with acute liver failure who are potential candidates for liver transplantation: a preliminary experience. 6th International Symposium on Albumin Dialysis, September 3rd–5th, Rostock-Warnemünde, Germany
Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L (1995) Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 222:109–119
Bernal W, Donaldson N, Wyncoll D, Wendon J (2002) Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 359:558–563
Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
Blei AT, Córdoba J (2001) Hepatic encephalopathy. Am J Gastroenterol 96:1968–1976
Kapoor D (2002) Molecular adsorbent recirculating system: Albumin dialysis-based extracorporeal liver assist device. J Gastroenterol Hepatol 17 Suppl 3:S280–S286
Boyle M, Kurtovic J, Bihari D, Riordan S, Steiner C (2004) Equipment review: the molecular adsorbents recirculating system (MARS). Crit Care 8:280–286
Awad SS, Swaniker F, Magee J, Punch J, Bartlett RH (2001) Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 130:354–362
Novelli G, Rossi M, Pretagostini R, Novelli L, Poli L, Ferretti G, Iappelli M, Berloco P, Cortesini R (2003) A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. Liver Int 23 Suppl 3:10–15
Mitzner S, Loock J, Peszynski P, Klammt S, Majcher-Peszynska J, Gramowski A, Stange J, Schmidt R (2002) Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS – a review of clinical, biochemical, and electrophysiological data. Metab Brain Dis 17:463–475
Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Lohr M, Liebe S, Schareck W, Hopt UT, Schmidt R (1999) Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23:319–330
Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, Hickstein H, Korten G, Schmidt R, Hentschel J, Schulz M, Lohr M, Liebe S, Schareck W, Hopt UT (2000) Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 6:603–613
Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R (2003) Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 38:24–31
Lai WK, Haydon G, Mutimer D, Murphy N (2005) The effect of molecular adsorbent recirculating system on pathophysiological parameters in patients with acute liver failure. Intensive Care Med. 31:1544–1549
Lamesch P, Jost U, Schreiter D, Scheibner L, Beier O, Fangmann J, Hauss J. Molecular adsorbant recirculating system in patients with liver failure (2001) Transplant Proc 33:3480–3482
Di Campli C, Zocco MA, Gaspari R, Novi M, Candelli M, Santoliquido A, Flore R, Tondi P, Proietti R, Gasbarrini G, Pola P, Gasbarrini A (2005) The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. Transplant Proc 37:2551–2553
Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, Jalan R (2004) Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 10:1109–1119
Isoniemi H, Koivusalo AM, Repo H, Ilonen I, Hockerstedt K (2005) The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation. Transplant Proc 37:1088–1090
Lee WM (1993) Acute liver failure. N Engl J Med 329:1862–1872
Lee WM (2003) Acute liver failure in the United States. Semin Liver Dis 23:217–226
Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM; U.S. Acute Liver Failure Study Group (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947–954
Lahdenperä A, Koivusalo AM, Vakkuri A, Hockerstedt K, Isoniemi H (2005) Value of albumin dialysis therapy in severe liver insufficiency. Transpl Int 17(11):717–723
Saliba F (2004) Liver failure: FULMAR Study. 6th International Symposium on Albumin Dialysis, September 3rd–5th, Rostock-Warnemünde, Germany
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Camus, C., Lavoué, S., Gacouin, A. et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 32, 1817–1825 (2006). https://doi.org/10.1007/s00134-006-0340-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-006-0340-1